Skip to Content

FDA strikes cautious tone ahead of vaccine booster meeting

Andrew Cuomo

By LAURAN NEERGAARD and MATTHEW PERRONE
Associated Press

WASHINGTON (AP) — U.S. government advisers will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective. It’s the first public step toward deciding which Americans may get an extra dose and when. The Food and Drug Administration on Wednesday posted much of the evidence that it will ask outside experts to consider at Friday’s meeting. But the agency struck a cautious tone in reviewing the data and discussing the rationale for boosters. That careful approach is notable given that White House officials have been previewing a booster campaign that they hoped to begin next week.

Article Topic Follows: AP National News

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KVIA ABC 7 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content